| All Releases |
 |
Metabolix Reports Second Quarter Financial Results and Provides Business Update
Jul 28, 2010 |
21 KB |
|
| |
CAMBRIDGE, Mass., Jul 28, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today reported financial results for the three months ended June 30,
2010.
The Company reported a net loss of $9.5 million or $0.36 per share ... |
|
|
Metabolix to Conduct a Webcast of Its Second Quarter 2010 Earnings Call
Jul 16, 2010 |
8 KB |
|
| |
CAMBRIDGE, Mass., Jul 16, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that it will be releasing its second quarter
2010 financial results after the market close on Wednesday, July 28,
... |
|
|
Telles Receives FDA Clearance for Mirel(TM) F1005 and F1006 Injection Molding Bioplastic Materials for Use in Food Contact Applications
May 11, 2010 |
11 KB |
|
| |
CAMBRIDGE, Mass., May 11, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX) and Archer Daniels Midland Company today
announced that Telles received U.S. Food and Drug Administration (FDA)
clearance for the formulated products Mirel(TM) F1005 and F1006, food
contact injection molding grades for use in food contact applic... |
|
|
Metabolix Reports First Quarter Financial Results and Provides Business Update
Apr 28, 2010 |
19 KB |
|
| |
CAMBRIDGE, Mass., Apr 28, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today reported financial results for the three months ended March 31,
2010.
The Company reported a net loss of $9.8 million or $0.37 per share... |
|
|
Metabolix to Conduct a Webcast of Its First Quarter 2010 Earnings Call
Apr 20, 2010 |
8 KB |
|
| |
CAMBRIDGE, Mass., Apr 20, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that it will be releasing its first quarter 2010
financial results after the market close on Wednesday, April 28, 2010. ... |
|
|
Metabolix Reports Fourth Quarter and Full Year Financial Results and Provides Business Update
Mar 10, 2010 |
21 KB |
|
| |
CAMBRIDGE, Mass., Mar 10, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today reported financial results for the three months and full year
ended December 31, 2009.
The Company reported a net loss of $9.8 million o... |
|
|
Metabolix to Conduct a Webcast of Its Fourth Quarter 2009 Earnings Call
Feb 19, 2010 |
8 KB |
|
| |
CAMBRIDGE, Mass., Feb 19, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that it will be releasing its fourth quarter and
full year fiscal 2009 financial results after the market close on
... |
|
|
World Economic Forum Selects Metabolix as a 2010 Technology Pioneer
Dec 3, 2009 |
10 KB |
|
| |
CAMBRIDGE, Mass., Dec 03, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for the plastics, chemicals and energy
industries, announced today that it has been named to the 2010 Class of
Technology Pioneers by the World Economic Forum (WEF).
To be select... |
|
|
Metabolix Announces Completion of Common Stock Offering
Nov 16, 2009 |
10 KB |
|
| |
CAMBRIDGE, Mass., Nov 16, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today announced the completion of its previously announced underwritten
public offering of 3,450,000 shares of its common stock at a price of
... |
|
|
Metabolix Prices Common Stock Offering
Nov 11, 2009 |
10 KB |
|
| |
CAMBRIDGE, Mass., Nov 11, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today announced that it has priced a public offering of 3.0 million
newly issued shares of its common stock at a public offering price of
... |
|
|
Metabolix Announces Commencement of Public Offering of Common Stock
Nov 10, 2009 |
10 KB |
|
| |
CAMBRIDGE, Mass., Nov 10, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today announced that it has commenced a public offering of shares of its
common stock pursuant to the Company's effective shelf registration
... |
|
|
Metabolix Reports Third Quarter Financial Results and Provides Business Update
Oct 29, 2009 |
20 KB |
|
| |
CAMBRIDGE, Mass., Oct 29, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
today reported financial results for the three months ended September
30, 2009.
The Company reported a net loss of $9.4 million or $0.41 per s... |
|
|
Metabolix and ADM Appoint Stan Haftka as Director of Business Development, Europe, for Telles Joint Venture
Oct 26, 2009 |
10 KB |
|
| |
CAMBRIDGE, Mass., Oct 26, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX) and Archer Daniels Midland Company today
announced the appointment of Stan Haftka, Ph.D., as Director of Business
Development, Europe, for Telles, the joint venture that is
commercializing Mirel(TM) bioplastics. Dr. Haftka will lead European
... |
|
|
Metabolix Completes Field Trial of Bioplastic-Producing Tobacco Crop
Oct 22, 2009 |
10 KB |
|
| |
CAMBRIDGE, Mass., Oct 22, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
announced today that it has completed a field trial of tobacco,
genetically engineered to express polyhydroxyalkanoate (PHA) biobased
p... |
|
|
Metabolix Announces that Pharmafilter Will Use Mirel(TM) Bioplastics in Innovative Hospital Waste Management System
Oct 19, 2009 |
12 KB |
|
| |
CAMBRIDGE, Mass., Oct 19, 2009 (BUSINESS WIRE) -- Pharmafilter BV, a bioenergy technology company based in Amsterdam, has
selected Mirel bioplastics for a suite of disposable products for
hospital use. Pharmafilter BV is currently commercializing its patented
Pharmafilter system as a cleaner, more efficient way for hospitals... |
|
|
Metabolix to Conduct a Webcast of Its Third Quarter 2009 Earnings Call
Oct 15, 2009 |
9 KB |
|
| |
CAMBRIDGE, Mass., Oct 15, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
announced today that it will be releasing its third quarter 2009
financial results after the close of market on Thursday, October 29,
2... |
|
|
Metabolix Awarded US Department of Agriculture Grant to Develop Biobased, Biodegradable Bottles
Oct 7, 2009 |
9 KB |
|
| |
CAMBRIDGE, Mass., Oct 07, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing sustainable solutions for plastics, chemicals and energy,
announced today that it has received a Grant from the USDA Cooperative
State Research, Education, and Extension Service (CSREES). The award
... |
|
|
Metabolix Appoints Johan van Walsem as Vice President of Commercial Development
Aug 3, 2009 |
8 KB |
|
| |
CAMBRIDGE, Mass., Aug 03, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, today announced that Johan van Walsem has joined the company as
Vice President of Commercial Development. Mr. van Walsem will be
... |
|
|
Metabolix Reports Second Quarter Financial Results and Provides Business Update
Jul 29, 2009 |
20 KB |
|
| |
CAMBRIDGE, Mass., Jul 29, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, today reported financial results for the three months ended June
30, 2009.
The Company reported a net loss of $9.7 million or $0.42 per... |
|
|
Metabolix, Inc. Adopts Shareholder Rights Plan
Jul 7, 2009 |
9 KB |
|
| |
CAMBRIDGE, Mass., Jul 07, 2009 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MLBX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that its Board of Directors has adopted a
Shareholder Rights Plan.
Richard Eno, President and CEO of Metabolix, stated,... |
|
|
|